{"id":"https://openalex.org/W2626820697","doi":"https://doi.org/10.1200/jco.2012.30.15_suppl.2501","title":"A phase I study of 1-methyl-D-tryptophan in patients with advanced malignancies.","display_name":"A phase I study of 1-methyl-D-tryptophan in patients with advanced malignancies.","publication_year":2012,"publication_date":"2012-05-20","ids":{"openalex":"https://openalex.org/W2626820697","doi":"https://doi.org/10.1200/jco.2012.30.15_suppl.2501","mag":"2626820697"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2012.30.15_suppl.2501","doi":"https://doi.org/10.1200/jco.2012.30.15_suppl.2501","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2012.30.15_suppl.2501","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090789911","display_name":"Hatem Hussein Soliman","orcid":"https://orcid.org/0000-0001-6644-2264","observed_orcids":["https://orcid.org/0000-0001-6644-2264"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hatem Hussein Soliman","raw_affiliation_strings":["H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030296219","display_name":"Anthony M. Neuger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anthony Neuger","raw_affiliation_strings":["H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111712584","display_name":"David R. Noyes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Noyes","raw_affiliation_strings":["H. Lee Moffitt Cancer Canter & Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Canter & Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070688456","display_name":"Nicholas N. Vahanian","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210127016","display_name":"NewLink Genetics (United States)","ror":"https://ror.org/03spep839","country_code":"US","type":"company","lineage":["https://openalex.org/I4210127016"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicholas N. Vahanian","raw_affiliation_strings":["NewLink Genetics, Ames, IA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NewLink Genetics, Ames, IA","institution_ids":["https://openalex.org/I4210127016"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112243123","display_name":"Charles J. Link","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210127016","display_name":"NewLink Genetics (United States)","ror":"https://ror.org/03spep839","country_code":"US","type":"company","lineage":["https://openalex.org/I4210127016"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charles J. Link","raw_affiliation_strings":["NewLink Genetics, Ames, IA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NewLink Genetics, Ames, IA","institution_ids":["https://openalex.org/I4210127016"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011462362","display_name":"David H. Munn","orcid":"https://orcid.org/0000-0002-7711-2858","observed_orcids":["https://orcid.org/0000-0002-7711-2858"]},"institutions":[{"id":"https://openalex.org/I25041050","display_name":"Augusta University","ror":"https://ror.org/012mef835","country_code":"US","type":"education","lineage":["https://openalex.org/I25041050"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Munn","raw_affiliation_strings":["Medical College of Georgia, Augusta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical College of Georgia, Augusta, GA","institution_ids":["https://openalex.org/I25041050"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090809833","display_name":"HOWARD Z. STREICHER","orcid":"https://orcid.org/0000-0003-3683-9804","observed_orcids":["https://orcid.org/0000-0003-3683-9804"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Howard Streicher","raw_affiliation_strings":["National Cancer Institute, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Cancer Institute, Bethesda, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102841436","display_name":"Daniel M. Sullivan","orcid":"https://orcid.org/0009-0003-0951-9781","observed_orcids":["https://orcid.org/0009-0003-0951-9781","https://orcid.org/0000-0002-2183-1773"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel Sullivan","raw_affiliation_strings":["H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5046273815","display_name":"Scott Joseph Antonia","orcid":"https://orcid.org/0000-0002-6686-3824","observed_orcids":["https://orcid.org/0000-0002-6686-3824"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Scott Antonia","raw_affiliation_strings":["H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":17,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"30","issue":"15_suppl","first_page":"2501","last_page":"2501"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8974999785423279,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8974999785423279,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0860000029206276,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12996","display_name":"Cancer Research and Treatments","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/1305","display_name":"Biotechnology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/1-methyl-d-tryptophan","display_name":"1-methyl-D-tryptophan","score":0.9599999785423279},{"id":"https://openalex.org/keywords/indoleamine-2-3-dioxygenase-inhibition","display_name":"indoleamine 2,3-dioxygenase inhibition","score":0.9599999785423279},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.5979999899864197},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.7870000004768372},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.7390000224113464},{"id":"https://openalex.org/keywords/autoimmune-hypophysitis","display_name":"autoimmune hypophysitis","score":0.8420000076293945},{"id":"https://openalex.org/keywords/tryptophan-catabolites","display_name":"tryptophan catabolites","score":0.8899999856948853},{"id":"https://openalex.org/keywords/regulatory-t-cells","display_name":"regulatory T cells","score":0.8899999856948853},{"id":"https://openalex.org/keywords/c-reactive-protein","display_name":"C-reactive protein","score":0.949999988079071},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.41200000047683716},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.6859999895095825},{"id":"https://openalex.org/keywords/sarcoma","display_name":"sarcoma","score":0.9739999771118164},{"id":"https://openalex.org/keywords/colon-cancer","display_name":"colon cancer","score":0.843999981880188},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.5920000076293945}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.878874659538269},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5453888177871704},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5125212669372559},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.46824729442596436},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.46733343601226807},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4662904143333435},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.4556901156902313},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.45195525884628296},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.4417153596878052},{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.42484724521636963},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.42367666959762573},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.40862518548965454},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.38447511196136475},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3120828866958618},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.21167197823524475}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2012.30.15_suppl.2501","doi":"https://doi.org/10.1200/jco.2012.30.15_suppl.2501","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2012.30.15_suppl.2501","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2738537222","https://openalex.org/W2344411250","https://openalex.org/W2044651251","https://openalex.org/W2791990204","https://openalex.org/W2953713780","https://openalex.org/W2811397538","https://openalex.org/W2898952503","https://openalex.org/W2028575737","https://openalex.org/W2609883123","https://openalex.org/W14660748"],"abstract_inverted_index":{"2501":[0],"Background:":[1],"The":[2,43,291],"indoleamine":[3],"2,":[4],"3":[5,121,164],"dioxygenase":[6],"pathway":[7],"(IDO)":[8],"can":[9],"create":[10],"immune":[11,36],"suppression":[12],"and":[13,41,54,71,111,187,202,245,261,272,296,310,315,324],"unresponsiveness":[14],"to":[15,50,184],"tumor":[16],"antigens":[17],"in":[18,32,118,231,269,274,301,312],"tumor-bearing":[19],"hosts.":[20],"1-methyl-D-tryptophan":[21],"(1-MT)":[22],"is":[23,49,181,257,264,288],"an":[24,35,176],"oral":[25,57],"inhibitor":[26],"of":[27,46,87,146,236,303,308],"the":[28,52,119,147,262],"IDO":[29,180],"pathway,":[30],"currently":[31],"development":[33],"as":[34,223,225],"adjuvant":[37],"for":[38,56],"anti-tumor":[39],"vaccines":[40],"chemotherapy.":[42],"primary":[44],"goal":[45],"this":[47,190],"trial":[48],"determine":[51],"MTD":[53,153],"toxicity":[55,134],"1-MT.":[58],"Secondary":[59],"endpoints":[60],"include":[61],"response":[62],"rates,":[63],"PK,":[64],"serum":[65],"tryptophan":[66],"catabolites,":[67],"circulating":[68],"T-reg":[69,275,313],"cells,":[70],"C":[72],"reactive":[73],"protein":[74],"(CRP)":[75],"levels.":[76,283],"Methods:":[77],"This":[78],"phase":[79],"I":[80],"study":[81],"utilizes":[82],"a":[83,237,325],"3+3":[84],"design":[85],"comprised":[86],"ten":[88],"dose":[89,282],"levels":[90,271,314],"(200,":[91],"300,400,600,800,mg":[92],"QD,":[93],"600,":[94],"800,1200,1600,2000mg":[95],"BID).":[96],"Inclusion":[97],"criteria:":[98,116],"patients":[99,150,165,196,213,233],"with":[100,168,197,249,322],"measurable":[101],"metastatic":[102],"solid":[103],"malignancy,":[104],"age":[105],"\u226518,":[106],"life":[107],"expectancy":[108],">4":[109],"months,":[110],"adequate":[112],"organ/marrow":[113],"function.":[114],"Exclusion":[115],"chemotherapy":[117],"past":[120],"weeks,":[122],"untreated":[123],"brain":[124],"metastases,":[125],"active":[126,169],"autoimmune":[127,177],"disease,":[128],"or":[129],"malabsorptive":[130],"GI":[131],"disease.":[132],"Continuous":[133],"monitoring":[135],"early":[136],"stopping":[137],"rules":[138],"were":[139,151,200,210,229,247,278,317],"used.":[140],"Results:":[141],"At":[142,160],"submission,":[143],"48":[144],"out":[145],"planned":[148],"50":[149],"accrued.":[152],"was":[154,191,293],"not":[155],"reached":[156],"at":[157,254,258,265],"2000mg":[158,255],"BID.":[159],"200mg":[161],"QD":[162],"dose,":[163],"previously":[166],"treated":[167],"immunotherapy":[170,199],"(ipilimumab,":[171],"n=2,":[172],"CD40-mAb,":[173],"n=1)":[174],"developed":[175],"hypophysitis.":[178],"Since":[179],"closely":[182],"linked":[183],"both":[185],"CTLA-4":[186],"CD40/CD40L":[188],"pathways":[189],"considered":[192],"on-target":[193],"effect.":[194],"Subsequently,":[195],"prior":[198],"excluded":[201],"no":[203],"additional":[204],"treatment":[205,292],"related":[206],"G3-5":[207],"adverse":[208],"events":[209],"observed.":[211,318],"Five":[212],"showed":[214],"SD>6":[215],"months":[216],"(2":[217],"melanoma,":[218],"2":[219],"sarcoma":[220],"1":[221],"colon)":[222],"well":[224,294],"some":[226,232],"mixed":[227],"responses":[228],"seen":[230,279],"including":[234],"regression":[235],"liver":[238],"visceral":[239],"metastases.":[240],"1-MT":[241,321],"plasma":[242],"PK":[243],"AUC":[244],"Cmax":[246,251],"proportional":[248],"dose.":[250],"(~40":[252],"\u03bcM":[253],"BID)":[256],"2.9":[259],"hours":[260],"t1/2":[263],"10":[266],"hours.":[267],"Elevations":[268],"CRP":[270,316],"declines":[273],"cell":[276,327],"counts":[277],"across":[280],"multiple":[281],"Additional":[284],"correlative":[285],"data":[286],"analysis":[287],"ongoing.":[289,330],"Conclusions:":[290],"tolerated":[295],"orally":[297],"bioavailable.":[298],"Biologic":[299],"activity":[300],"terms":[302],"prolonged":[304],"disease":[305],"stabilization,":[306],"induction":[307],"hypophysitis,":[309],"changes":[311],"Trials":[319],"combining":[320],"docetaxel":[323],"dendritic":[326],"vaccine":[328],"are":[329]},"counts_by_year":[{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":4}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2017-06-23T00:00:00"}